University of Oxford and 2U Launch AI in Drug Discovery and Medicine Programme
核心洞察
The Nuffield Department of Medicine (搜索) at the University of Oxford and 2U (搜索) have launched a six-week online executive education program focused on applying artificial intelligence across the drug discovery pipeline.
The Oxford AI in Drug Discovery and Medicine Programme equips scientists, researchers, and R&D professionals with AI skills spanning target identification, biomarker discovery, patient stratification, and therapeutic prediction.
The curriculum integrates ethical, legal, and regulatory considerations, including algorithmic bias, model explainability, and responsible deployment, with no coding experience required.
2U (搜索), a global leader in higher education, and the Nuffield Department of Medicine (搜索) (NDM) at the University of Oxford have announced a new partnership to launch the Oxford AI in Drug Discovery and Medicine Programme. The six-week online executive education program, announced on September 3, 2026, is designed to equip scientists, researchers, and R&D professionals to apply artificial intelligence across the drug discovery pipeline while navigating the ethical and regulatory standards essential to modern biomedical research.
The program marks the beginning of 2U (搜索)'s partnership with the Nuffield Department of Medicine (搜索) and further expands its growing relationship with the University of Oxford. The partnership now spans more than 40 online executive education programs and open courses delivered on edX, bringing together leading Oxford schools—including Saïd Business School, the Faculty of Law, the Blavatnik School of Government, and now the Nuffield Department of Medicine—to deliver education in areas of rapidly growing global demand.
"Artificial intelligence is creating new opportunities to accelerate biomedical discovery, but realizing its full potential requires scientists who understand not only the technology, but also the scientific, ethical, and regulatory context in which it is applied," said Dr Abigail Rickard, Head of Academic Programmes, Nuffield Department of Medicine (搜索), University of Oxford. "This program combines our expertise in biomedical research with practical applications of AI, giving professionals the knowledge and tools to translate emerging technologies into meaningful advances in drug discovery and medicine."
Curriculum and Technical Applications
The program was developed by faculty with a track record in open-science research, spanning leading international drug discovery initiatives during the COVID-19 pandemic to OpenBind, an open-science consortium building the world's largest public dataset linking protein structures to binding measurements. Participants explore how AI can support target identification, biomarker discovery, patient stratification, and therapeutic prediction while working with industry tools including MedChemica (搜索) and Target Safety (搜索). No coding experience is required.
Alongside technical applications, the curriculum examines the ethical, legal, and regulatory considerations surrounding AI in medicine, including algorithmic bias, model explainability, and responsible deployment. Participants complete practical assessments throughout the program, culminating in an AI implementation roadmap they can apply within their own organizations.
Expanding Partnership and Future Offerings
"One of the advantages of a long-term partnership is the ability to grow alongside an institution as its priorities evolve," said Andy Morgan, Chief Partnerships Officer at 2U (搜索). "Over the past several years, our relationship with the University of Oxford has expanded across schools and disciplines in response to growing learner demand. Our collaboration with the Nuffield Department of Medicine (搜索) is another example of that momentum, with additional programs already planned."
A second executive education offering from NDM, the Oxford Nuffield Healthcare Management Programme, is expected to launch later this year, further extending the collaboration into life sciences and healthcare. The Oxford AI in Drug Discovery and Medicine Programme reflects 2U (搜索)'s strategy of helping leading universities extend their reach through long-term partnerships that evolve alongside learner and workforce demand.
2U (搜索) partners with the world's top universities and companies to build education programs that accelerate careers and transform lives. Through more than 250 institutional and enterprise partnerships, 2U develops and delivers over 5,300 online programs, reaching more than 100 million people worldwide through edX, its global learning platform.